James A. Schoeneck, Director at Calidi Biotherapeutics, Inc. (CLDI), bought 75,000 shares at $2.00 ($150K) on 2025-08-21, disclosed to the SEC on 2025-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| FGEN | SELL | 2023-06-09 | $256K | — | Filing → |
| FGEN | SELL | 2019-05-09 | $94K | — | Filing → |
| FGEN | SELL | 2019-04-10 | $106K | — | Filing → |